CS
PHGE icon

Clear Street’s BiomX PHGE Stock Holding History

Clear Street’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-120
Closed -$224 – 1152
2025
Q4 		$224 Buy
120
+1
+0.8% +$7 ﹤0.01% 895
2025
Q3 		$1.19K Hold
119
– – ﹤0.01% 768
2025
Q2 		$1.02K Sell
119
-5
-4% -$50 ﹤0.01% 610
2025
Q1 		$1.31K Sell
124
-6
-5% -$84 ﹤0.01% 482
2024
Q4 		$1.8K Buy
130
+72
+124% +$1.02K ﹤0.01% 472
2024
Q3 		$1.12K Buy
+58
New +$2.1K ﹤0.01% 583

Other funds holding PHGE

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Clear Street's PHGE Position: Q1 2026 in Review

Clear Street sold out of BiomX (PHGE) in Q1 2026, closing a stake of 120 shares — an estimated $224 sold.

Clear Street first reported a position in PHGE in Q3 2024 and held it in 6 quarters. The position peaked at $1.8K in Q4 2024. 13 funds tracked by Wall St. Rank hold PHGE as of Q1 2026.

  • Clear Street reported no remaining BiomX position as of Q1 2026 after selling out during the quarter.
  • Clear Street sold 120 BiomX shares in Q1 2026, an estimated $224.
  • Clear Street first reported a position in BiomX in Q3 2024 and held it in 6 quarters.
  • Clear Street's BiomX position peaked at $1.8K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held BiomX as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.